I like this: 😍The cost-saving impact of human papillomavirus self-sampling for cervical cancer screening in women workers at the manufacturing sector in Ciudad Juárez, Chihuahua, Mexico https://t.co/x7eggdFQbK
In California, #cervicalcancer reveals a clear equity gap: Hispanic women have a 34.7% higher incidence and a 21% higher mortality rate compared with the overall population. The main drivers are barriers in access to healthcare, social determinants of health, limited data visibility for some groups, and shortfalls in program implementation and follow-up. These figures show how far we still are from eliminating cervical cancer; the first cancer that can be eliminated with relatively modest, well-targeted investment in screening, HPV vaccination, and equitable access.
When a working woman develops cervical cancer, the impact goes far beyond her health: it reduces household income, lowers company productivity, and increases costs for the social security system through disability payments and pensions.
https://t.co/kdTnn5Ghu7
Doctors and Nurses across OECD Countries
Top 5 Countries
Norway🇳🇴
Switzerland🇨🇭
Iceland🇮🇸
Germany🇩🇪
Finland🇫🇮
Bottom 5 Countries
Colombia🇨🇴
Türkiye🇹🇷
Mexico🇲🇽
Chile🇨🇱
Costa Rica🇨🇷
@OECD
Public Social Spending
Top 5 Countries
Austria🇦🇹
Finland🇫🇮
France🇫🇷
Belgium🇧🇪
Germany🇩🇪
Bottom 5 Countries
Mexico🇲🇽
Türkiye🇹🇷
Costa Rica🇨🇷
Chile🇨🇱
Colombia🇨🇴
@OECD
Nine-Valent Human Papillomavirus Vaccination and Related Cancers in Males | Cancer Screening, Prevention, Control | JAMA Oncology | JAMA Network https://t.co/hiAX1WzpRv
Across Africa, important progress is being made in #HPV vaccination and cervical cancer screening. How can these efforts be sustained & scaled?
Join us on May 13 to hear practical lessons, implementation challenges, and sustainable approaches.
🔗https://t.co/3DOXM5MpKM
⏳24 hours left
This is your final opportunity to be part of the #IPVS2026 scientific program bringing together the global #HPV research community in Athens.
📅Final submission deadline: May 12
🔗Submit now: https://t.co/wNVujDvqkn
#HPVResearch#GlobalHealth#ScientificProgram
En 2024 el cáncer de colon es ya la principal causa de muerte por cáncer en México con 8,837 defunciones, superando al cáncer de mama por 398 muertes. En números absolutos la velocidad con la que se ha incrementado a partir de 2010 es casi de terror. A su lado el cáncer de mama, primera causa de muerte por un cáncer en la mujer.
Australia is on track to become the first country to eliminate cervical cancer, largely because of a national vaccination program to prevent the disease. https://t.co/T5KWI7bqso
Because aspirin helps reduce inflammation, it's been tested as a way to prevent conditions related to long-term inflammation, including colon cancer. #HarvardHealth
https://t.co/SDlwBEOIHi
In case you missed it…
In our February webinar, we explored how AI can transform cervical cancer screening programs and support cost-effective digital registries.
Explore the highlights from each presentation👇
Members can access the full recording➡️https://t.co/0K4kJd7dra
Cuando una mujer trabajadora enferma de cáncer cérvico uterino, el impacto no es solo en su salud: afecta el ingreso en su hogar, la productividad de su empresa y aumenta el gasto en incapacidades y pensiones para la institución de seguridad social.
El siguiente artículo: The cost-saving impact of human papillomavirus self-sampling for cervical cancer screening in women workers at the manufacturing sector in Ciudad Juárez, Chihuahua, Mexico; muestra que la autotoma de VPH en el lugar de trabajo es mejor que el Pap para proteger a las trabajadoras, a sus familias y los recursos públicos:
• +61% detección de lesiones de alto grado
• 68% menor costo por caso prevenido
• 67% menos días de incapacidad pagados
https://t.co/UEcGT5tQpG
#AutotomaVPH #CáncerCervicouterino #MujeresTrabajadoras #IMSS #SaludLaboral
In this infographic you have a structured synthesis of current screening recommendations based on official guidance from:
➡️ United States: U.S. Preventive Services Task Force (USPSTF), American Cancer Society (ACS).
➡️ Europe: European Commission (EU Council Recommendations 2022 update), and position statements from European Society for Medical Oncology (ESMO).
➡️ Only population-based screening with sufficient evidence is included.
#Microplastics are plastic fragments smaller than 5 mm that results from breakdown of plastic litter.
📄 This JAMA Patient Page describes microplastics and the potential health effects of human exposure to microplastics.
https://t.co/9Rs44aFr4Y